[1]Diwanji R, O'Brien N A, Choi J E, et al. Targeting the IL1β Pathway for Cancer Immunotherapy Remodels the Tumor Microenvironment and Enhances Antitumor Immune Responses[J]. Cancer Immunology Research, 2023.
[2]Grauel A L, Nguyen B, Ruddy D, et al. TGFβ-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts[J]. Nature communications, 2020, 11: 6315.